Cell-cell adhesions are a hallmark of epithelial tissues, and the disruption of these contacts plays a critical role in both the early and late stages of oncogenesis. The interaction between the transmembrane protein E-cadherin and the intracellular protein β-catenin plays a crucial role in the formation and maintenance of epithelial cell-cell contacts and is known to be downregulated in many cancers. The authors have developed a protein complex enzyme-linked immunosorbent assay (ELISA) that can quantify the amount of β-catenin bound to E-cadherin in unpurified whole-cell lysates with a Z′ factor of 0.74. The quantitative nature of the E-cadherin:β-catenin ELISA represents a dramatic improvement over the low-throughput assays currently used to characterize endogenous E-cadherin:β-catenin complexes. In addition, the protein complex ELISA format is compatible with standard sandwich ELISAs for parallel measurements of total levels of endogenous E-cadherin and β-catenin. In 2 case studies closely related to cancer cell biology, the authors use the protein complex ELISA and traditional sandwich ELISAs to provide a detailed, quantitative picture of the molecular changes occurring within adherens junctions in vivo. Because the E-cadherin: β-catenin protein complex plays a crucial role in oncogenesis, this protein complex ELISA may prove to be a valuable quantitative prognostic marker of tumor progression. (Journal of Biomolecular Screening 2007:683-693) 
INTRODUCTION
C ELL-CELL ADHESIONS are an integral aspect of epithelial tissues. These adhesions provide a physical barrier between 2 compartments, permitting the epithelial cell layer to serve as a selective transporter. Moreover, the attenuation of cell-cell adhesion plays a critical role in both early and late stages of oncogenesis. 1 At early steps, reduced intercellular adhesion may attenuate contact inhibition of proliferation, permitting unchecked cell division and tumor formation; at later stages, reduced cell-cell adhesion is often associated with invasion, metastasis, and poor patient prognosis. 2 In epithelial tissues, adherens junctions play a central role in the establishment and maintenance of cell-cell adhesions. 3 These junctions are composed of the cadherin and catenin families of proteins, which link sites of cell-cell contact to the actin cytoskeleton. Cadherins are transmembrane proteins that bind homotypically to cadherins on neighboring cells; meanwhile, the intracellular tail of cadherins binds β-catenin, which then recruits α-catenin and links to the actin cytoskeleton. In epithelial tissues, E-(epithelial) cadherin is the predominant member of the cadherin family expressed, and the loss of E-cadherin via genetic and epigenetic mechanisms is common in tumor progression. 4 Given their integral role in forming and maintaining cell-cell adhesion, the interaction of E-cadherin and β-catenin has been widely studied. The most common method for assaying the expression and subcellular localization of endogenous E-cadherin and β-catenin in pathological contexts is histochemistry. 5, 6 Although informative, these methods are low throughput and offer only qualitative information. Other more quantitative approaches have been developed to examine the molecular mechanisms governing E-cadherin:β-catenin association, including bead-based co-immunoprecipitation techniques (co-IP), [7] [8] [9] semi-quantitative immunofluorescence, 10 recombinant protein pull-down assays, 11, 12 and chip-based biosensors. 13 Co-IP assays, in particular, have been widely used to measure the association of endogenous E-cadherin and β-catenin; however, this technique involves cumbersome and repetitive centrifugation and 1 wash steps, as well as low-throughput handling of multiple test tubes. Furthermore, the proteins isolated by co-IP are typically analyzed by Western blotting, which offers a limited linear range of detection. In contrast, other techniques using recombinant proteins provide quantitative measures of E-cadherin:β-catenin interactions over a wide linear range; 12, 13 however, these in vitro binding assays may not reflect in vivo biology.
We have developed a protein complex enzyme-linked immunosorbent assay (ELISA) that addresses many of the limitations in current methods for quantifying the amount of endogenous E-cadherin:β-catenin complexes. The microtiter format is also highly compatible with the standard sandwich ELISA for parallel measurements of total protein levels. In 2 case studies closely related to cancer cell biology, we demonstrate that the protein complex ELISA, in conjunction with parallel measurements of total protein, offers a detailed, quantitative picture of the molecular changes occurring within adherens junctions in vivo.
MATERIALS AND METHODS

Cell culture
MCF-10A cells were cultured in Dulbecco's modified Eagle's medium/Ham's F-12 containing HEPES and L-glutamine (Invitrogen, Carlsbad, CA) supplemented with 5% (v/v) horse serum (Invitrogen), 20 ng/mL epidermal growth factor (EGF; Peprotech, Rocky Hill, NJ), 0.5 µg/mL hydrocortisone (Sigma, St. Louis, MO), 0.1 µg/mL cholera toxin (Sigma), 10 µg/mL insulin (Sigma), and 1% (v/v) penicillin/streptomycin (Invitrogen). SW480 and 293T cells were cultured in Dulbecco's modified Eagle's medium supplemented with 4 mM L-glutamine (Invitrogen), 10% (v/v) fetal bovine serum (Invitrogen), and 1% (v/v) penicillin/streptomycin (Invitrogen).
Cell lysis
Cells were washed twice in ice-cold phosphate-buffered saline (PBS) and scraped into cold modified radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-Cl [pH 7.5], 150 mM NaCl,
.3], 10 mM NaPP, 30 mM NaF, 1 mM benzamidine, 2 mM ethylene glycol bis(2-aminoethyl)-tetraacetic acid (EGTA), 1 mM sodium orthovanadate, 1 mM dithiothreitol, 5 µg/mL aprotinin, 5 µg/mL leupeptin, 1 µg/mL pepstatin, and 1 mM phenylmethylsulfonyl fluoride). After incubation on ice for 15 min, the cell lysates were clarified by centrifugation, and the supernatant was collected as whole-cell lysate. The protein concentrations were determined using bicinchoninic acid (BCA) reagents (Sigma).
Protein complex and standard ELISAs
Mouse monoclonal capture antibodies against either E-cadherin or β-catenin (BD Transduction Laboratories, San Jose, CA) were diluted to 2.5 µg/mL in Tris-buffered saline (10 mM Tris [pH 8.0], 150 mM NaCl) containing 0.02% (v/v) sodium azide. Then, 100 µL of the diluted capture antibody was added to a flatbottom, high-protein-binding 96-well microplate (Corning, Corning, NY) and incubated overnight at room temperature. The next day, the wells were blocked with 150 µL of blocking buffer (10% [v/v] horse serum [Invitrogen] in TBST [Tris-buffered saline plus 0.05% (v/v) Tween-20]) for 2 h at room temperature. After washing the wells 3 times with TBST, whole-cell lysate was diluted in modified RIPA buffer to a final volume of 100 µL and added to each well for 2 h at 37 °C. The wells were then washed 3 times with TBST, and 100 µL of either anti-E-cadherin or anti-β-catenin rabbit polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA) diluted to 1 µg/mL in blocking buffer was added to each well and incubated for 1 h at 37 °C. The wells were washed 3 times with TBST, and the alkaline phosphatase-conjugated, antirabbit IgG secondary antibody (Biosource, Camarillo, CA) was diluted to 1 µg/mL in blocking buffer, and 100 µL was added to each well for 1 h at 37 °C. For detection, the wells were washed 3 times with TBST and once with Tris-buffered saline (TBS), and then 100 µL of 1 mg/mL p-nitrophenyl phosphate (Sigma) dissolved in reaction buffer (1 M diethanolamine, 0.05 mM MgCl 2 , pH 9.5) was added to each well. The absorbance at 405 nm was monitored by kinetic read at 37 °C at 17-s intervals over a period of 22 min using a microplate reader (Molecular Devices, Sunnyvale, CA). The rate of change in A405 over time was taken as the assay signal.
For the standard sandwich ELISA, both the capture and the detection antibody targeted the same protein (e.g., monoclonal and polyclonal anti-E-cadherin); for the protein complex ELISAs, the capture and detection antibodies targeted different halves of the E-cadherin:β-catenin protein complex (e.g., monoclonal anti-E-cadherin followed by polyclonal anti-β-catenin).
Validation of protein capture by Western blotting
Varying amounts of whole-cell lysate were incubated in the wells of a microplate that had been coated with either monoclonal anti-E-cadherin or anti-β-catenin antibody and blocked with blocking buffer. After incubation of the whole-cell lysate, the plate was washed 3 times with TBST, and then 100 µL of 1× sodium dodecyl sulfate (SDS) sample buffer (2% SDS, 0.1 M dithiothreitol, 60 mM Tris [pH 6.8], and 5% [v/v] glycerol diluted in modified RIPA buffer) was added to the wells. The microplate was then incubated for 5 min at 100 °C, and the contents of the wells were collected, resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) on 10% poly-acrylamide gels, and blotted onto nitrocellulose membrane (Bio-Rad, Hercules, CA). The membranes were blocked overnight and then incubated sequentially with primary monoclonal and corresponding horseradish peroxidase-conjugated secondary antibody. The blots were treated with SuperSignal West Femto Substrate (Pierce, Rockford, IL) and imaged on VersaDoc 3000 (Bio-Rad) using Quantity One software (Bio-Rad).
Plasmid constructs
pLNCX-Src-Y527F was generously provided by J. Brugge (Harvard Medical School). VSV-G and gag-pol vectors were gifts from D. Schaffer (University of California, Berkeley).
Retroviral infection
Retrovirus was produced by triple transfection of 293T cells with 5 µg each of VSV-G, gag-pol, and the retroviral vectors pLNCX or pLNCX-Src-Y527F using LipofectAMINE (Invitrogen) as previously described. 14 For infection, MCF-10A cells were incubated with retrovirus-containing growth medium and 8 µg/mL polybrene (Sigma) for 24 h; after infection, cells were selected with 200 µg/mL geneticin (Invitrogen) for 14 days.
Data analysis and statistical calculations
The signal-to-noise ratio (S/N) was calculated as
where µ s and µ b represent the means of the signal and the background, respectively, and σ s denotes the standard deviation of the assay signal. Z′ factors were calculated according to the equation
where µ s , µ b , and σ s are as defined above, and σ b is the standard deviation of the blank. 15 The S/N ratio and the Z′ factor were calculated at 200 µg and 130 µg of whole-cell lysate for the protein complex ELISAs and the sandwich ELISAs, respectively.
For the studies comparing the expression of E-cadherin, βcatenin, and E-cadherin:β-catenin complexes between cell types (see Fig. 5 ) or between cells infected with a dominantactive oncogene or an empty vector control (see Fig. 6 ), linear regressions were performed with total cell protein as the dependent variable and the assay signal (rate of change in optical density at 405 nm over time) as the independent variable, as shown in Supplemental Figures 1 and 2 . The statistical significance of the observed difference in slopes was calculated by analysis of covariance (ANCOVA).
RESULTS AND DISCUSSION
Development and validation of a quantitative microtiter ELISA for E-cadherin:β β-catenin protein complexes
Changes in E-cadherin:β-catenin interactions modulate cell-cell interactions and contribute to cell invasiveness and epithelial-mesenchymal transition. 1 To better quantify the level of E-cadherin:β-catenin association, we sought to develop a microtiter immunoassay built on the format of the traditional sandwich ELISA. In contrast to the sandwich ELISA, which measures the levels of a single protein, the protein complex ELISA quantifies the level of an endogenous protein complex, as has been previously described for several other protein complexes. [16] [17] [18] The assay uses an antibody to capture an antigen from unpurified whole-cell lysate, similar to a sandwich ELISA; however, rather than employ a detection antibody against the captured antigen, as in a sandwich ELISA, the protein complex ELISA uses a detection antibody targeting a purported binding partner of the captured antigen. For example, to measure the E-cadherin:β-catenin protein complex, one might use an anti-E-cadherin antibody for the initial capture step, followed by an anti-β-catenin antibody for detection of β-catenin associated with the captured E-cadherin. Thus, although both free and β-catenin-bound E-cadherin would be captured in the initial step, the protein complex ELISA is designed to selectively detect β-catenin in complex with E-cadherin. The amount of detection antibody can then be measured using an alkaline phosphatase-conjugated secondary antibody and the colorimetric substrate p-nitrophenyl phosphate (PNPP), where the rate of change in optical density at 405 nm provides a quantitative measure of detection antibody present.
The protein complex ELISA hinges on the possibility that capturing an antigen from crude cell lysates will coprecipitate associated proteins. This coprecipitation is exploited in IPbased detection of protein-protein complexes, a technique that involves the low-throughput, cumbersome use of test tubes in repeated centrifugation and wash steps. To verify that coprecipitation would occur in a microtiter format, we used a monoclonal anti-E-cadherin antibody to capture E-cadherin from whole-cell lysate and subsequently treated the wells with SDS sample buffer to extract all proteins. For this initial test, we used lysates from an immortalized mammary epithelial cell line (MCF-10A) that forms adherens junctions rich in Ecadherin:β-catenin complexes.
Analyzing protein extracts from microtiter wells by SDS-PAGE and Western blot demonstrated that the anti-E-cadherin monoclonal antibody efficiently captured E-cadherin from whole-cell lysates (Fig. 1A) . Importantly, β-catenin coprecipitated with E-cadherin; in fact, the amount of β-catenin increased with the amount of whole-cell lysate used in the assay. Furthermore, the "reverse" cocapture also worked in the microtiter format ( Fig. 1B) . Using a monoclonal anti-β-catenin antibody as the capture antibody allowed efficient capture of βcatenin and associated E-cadherin. Again, the amount of captured β-catenin and cocaptured E-cadherin increased with the amount of whole-cell lysate used in the assay, suggesting that cocapture may have a broad dynamic range.
Although the cocaptured protein is detectable by Western blot after stripping the wells, it is not clear whether the amount E-Cadherin:β β-Catenin Protein Complex ELISA of cocaptured protein is sufficient to detect using the microtiter immunoassay protocol. To address this question, we applied the protein complex ELISA to detect the amount of β-catenin that is bound to E-cadherin. We used a monoclonal anti-E-cadherin antibody to capture E-cadherin from cell lysate and then detected cocaptured β-catenin using a polyclonal anti-β-catenin antibody. The protein complex ELISA exhibits a linear response over the entire range of whole-cell lysate used in this study (0-200 µg) ( Fig. 2A) . Furthermore, the amount of β-catenin cocaptured with E-cadherin was detectable in as little as 10 µg of whole-cell lysate, and the S/N ratio was approximately 8 ( Table 1) . Indicative of the protein complex ELISA's robustness, the statistical parameter used for evaluation of high-throughput screens (Z′) for this E-cadherin:β-catenin ELISA was 0.74.
We also tested the reverse protein complex ELISA by capturing β-catenin with the mouse monoclonal antibody and then detecting E-cadherin with a polyclonal anti-E-cadherin antibody. The β-catenin:E-cadherin ELISA also demonstrated a broad linear dynamic range over 0 to 200 µg of whole-cell lysate (Fig. 2B) . However, the β-catenin:E-cadherin format was slightly less sensitive than the E-cadherin:β-catenin ELISA, as the S/N ratio of this assay was only 6.2 ( Table 1) . However, this assay still demonstrates good suitability to screening assays, with a Z′ factor of 0.59.
The relatively poorer performance of the β-catenin:E-cadherin ELISA is consistent with the full profile of in vivo protein: protein interactions in which β-catenin and E-cadherin participate. Whereas the β-catenin-binding domain of E-cadherin also recruits plakoglobin, a close homolog of β-catenin, 3 the Armadillo repeat domains of β-catenin bind numerous proteins, including α-catenin, Tcf/Lef, and components of the axin-APC degradation machinery. 19 Thus, in principle, for a fixed Ecadherin:β-catenin binding affinity in a particular cell lysate, captured E-cadherin should generate more cocaptured β-catenin signal than the cocapture of E-cadherin by β-catenin. However, although this physiological explanation could explain the better performance of the E-cadherin:β-catenin ELISA, we cannot rule out assay-related issues, such as relatively poorer efficacy of the monoclonal capture antibody for β-catenin versus E-cadherin.
The results reported for the protein complex ELISAs were collected using optimal assay conditions; all other formats and conditions tested were found to be suboptimal in terms of signal strength and S/N ratio. For example, we attempted to increase the amount of properly oriented capture antibody coated on the well by first adsorbing neutravidin, followed by incubation with a biotinylated secondary antibody that would bind the Fc domain of the capture antibody. Although this approach has been reported to increase antigen capture elsewhere, 20 the neutravidin/biotin approach reduced the signal/background ratio of our protein complex ELISA by approximately 5-fold compared to direct adsorption of the capture antibody (data not shown). The reduced sensitivity resulted from a nonspecific interaction between neutravidin and the alkaline phosphatase-conjugated secondary antibody used in the detection phase of the assay. In other stages of assay development, we observed that the monoclonal antibody outperformed the polyclonal antibody in the capture step. For example, in the case of the E-cadherin:β-catenin ELISA, using the mouse monoclonal antibody for the antigen capture step yielded a ~6-fold higher signal/background ratio than when the rabbit polyclonal antibody was used for capture (data not shown). In addition, we explored the effect of the incubation temperature on assay sensitivity, but protein complex ELISAs carried out at 4 °C and 37 °C showed no difference in assay sensitivity (data not shown). All results reported here are from assays conducted at 37 °C.
To verify that the protein complex ELISA specifically measures the interaction of E-cadherin and β-catenin, we performed the E-cadherin:β-catenin ELISA but omitted portions of the capture antibody:protein complex:detection antibody bridge that presumably forms in the microtiter well. Omission of the cell lysate, the anti-E-cadherin capture antibody, or the anti-β-catenin detection antibody completely ablated the assay signal ( Fig. 3) , demonstrating that a measurable assay signal is produced only when the complete antibody:protein:antibody sandwich is established. Given that these antibodies specifically recognize only 1 protein in Western blots (data not shown), combined with the fact that these antibodies can mediate capture of protein complexes in a microtiter well ( Fig. 1) , this demonstrates that the protein complex ELISA is specifically measuring the interaction of E-cadherin and β-catenin.
Compatibility of the protein complex ELISA with standard sandwich ELISAs
Our results demonstrate that the protein complex ELISA offers a quantitative method for measuring the amount of endogenous E-cadherin:β-catenin complexes in crude cell lysates. A key consideration, however, is that any measured change in the level of protein:protein complexes may be to due to a change in either protein:protein affinity or protein expression level. To discriminate between these possibilities, it is essential to measure the total amount of each protein in wholecell lysates. To address this issue, we exploited the flexibility of the protein complex ELISA to accommodate the traditional sandwich ELISA.
Having demonstrated that both E-cadherin and β-catenin are captured effectively in microtiter wells (Fig. 1) , we determined whether the amount of captured antigen may be detected using polyclonal anti-E-cadherin and anti-β-catenin antibodies in a sandwich ELISA format. Under the optimal detection conditions, E-cadherin was detected over a linear range spanning a wide range of whole-cell lysate (0-130 µg) (Fig. 4A) . Notably, the linear range of the E-cadherin sandwich ELISA extended only to 130 µg, as opposed to the protein complex ELISAs, which demonstrated linearity to at least 200 µg of total cell protein. The linear dynamic range of the standard sandwich ELISA may saturate at a lower amount of total cell protein compared to the protein complex ELISA because not all E-cadherin molecules are bound to β-catenin and vice versa. Nonetheless, the E-cadherin sandwich ELISA demonstrated an outstanding S/N ratio of 48, with a Z′ factor of 0.80 ( Table 1) . Using the same conditions as in the E-cadherin sandwich ELISA, we tested the detection of β-catenin using monoclonal and polyclonal anti-βcatenin antibodies for capture and detection, respectively. As for E-cadherin, β-catenin detection was linear up to 130 µg of total cell protein ( Fig. 4B) , with an S/N ratio of 3.6 ( Table 1) .
The β-catenin ELISA, in contrast to the E-cadherin sandwich ELISA, appears only marginally suitable for screening assays, with a Z′ factor of only 0.19. However, these results show that the protein complex ELISA is readily compatible with the sandwich ELISA for detecting total protein levels. This compatibility suggests that these assays may be operated on the same microtiter platform in parallel, reducing interplate variabilities and enhancing measurement throughput.
Quantitative comparison of E-cadherin:β β-catenin interactions in transformed versus nontransformed cells
To test the applicability of the protein complex and the total protein ELISAs, we quantified the amount of E-cadherin:βcatenin complexes and the expression level of E-cadherin and β-catenin in a transformed and a nontransformed cell system. The nontransformed mammary epithelial cell line, MCF-10A, exhibits a normal epithelial phenotype, including E-cadherinmediated intercellular adhesion; 21 meanwhile, SW480 is a colon carcinoma cell line with a dysfunctional β-catenin degradation machinery that permits β-catenin to build up to high levels in the cytoplasm. 22 To confirm that SW480 cells express greater amounts of βcatenin than MCF-10A cells, we used the β-catenin sandwich ELISA. The β-catenin sandwich ELISA yielded a linear response with respect to the amount of whole-cell lysate load in the assay for both cell types (For Supplemental Fig. 1 , see http://jbx.sagepub.com/cgi/content/full/12/5/683/DC1). We quantified the slope of the ELISA signal versus the amount of whole-cell lysate as a metric of the amount of β-catenin. As shown in Figure 5A , the amount of β-catenin per µg of cell lysate was nearly 10-fold higher in SW480 cells than in MCF-10A cells, consistent with the known dysfunction of β-catenin degradation in SW480 cells.
We next examined how excessive stabilization of β-catenin might affect the level of E-cadherin:β-catenin complexes in SW480 cells relative to those found in the MCF-10A cell line. As shown in Figure 5B , the E-cadherin:β-catenin ELISA revealed that MCF-10A cells exhibit approximately 2-fold higher levels of E-cadherin:β-catenin complexes than SW480 cells. Thus, despite a 10-fold relative abundance in β-catenin expression, the amount of E-cadherin:β-catenin complexes is fewer in SW480 cells than in MCF-10A cells.
To gain more insight into what may be limiting E-cadherin: β-catenin complex formation in SW480 cells, we quantified the E-cadherin expression level in the 2 cell lines using the sandwich ELISA, revealing that SW480 cells express approximately 2-fold lower levels of E-cadherin per µg of total cell lysate than MCF-10A cells (Fig. 5C) . This 2-fold reduction in E-cadherin expression mirrors the 2-fold decrease in Ecadherin:β-catenin complexes in SW480 cells, suggesting that the limiting factor in E-cadherin:β-catenin complex formation in SW480 cells is the reduced expression of E-cadherin. In fact, when the levels of E-cadherin:β-catenin are normalized to the total amount of E-cadherin, MCF-10A and SW480 show nearly identical values, with SW480 cells showing only a 30% ± 24% decrease compared to MCF-10A cells (Fig. 5D) . This suggests that, per E-cadherin molecule, there is no significant difference in binding affinity for β-catenin between the 2 cell types, although direct measurements are needed to confirm this hypothesis. Thus, the limiting factor in the formation of adherens junctions in SW480 appears to be expression of E-cadherin, especially because SW480 cells express roughly 10-fold higher levels of β-catenin than MCF-10A cells.
To gauge the relative differences in the fraction of cellular β-catenin engaged with E-cadherin between the 2 cell lines, we normalized the amount of E-cadherin:β-catenin complexes to total levels of β-catenin, as measured by the β-catenin sandwich ELISA. The fraction of cellular β-catenin that is engaged with E-cadherin is approximately 20-fold higher in MCF-10A cells relative to SW480 cells (Fig. 5D) . This result indicates that SW480 cells possess a much larger pool of β-catenin that is not bound to E-cadherin. Evidently, this arises because SW480 cells express very high levels of total β-catenin with a concomitant decrease in the levels of total E-cadherin, leaving a large fraction of β-catenin unbound to E-cadherin. This pool of unbound β-catenin molecules may contribute to the constitutive activation of transcriptional targets by β-catenin in SW480. 23
Quantitative analysis of the effect of constitutively active Src on E-cadherin:β β-catenin interactions
As another application of our quantitative protein complex ELISA, we quantified the effect of the tyrosine kinase Src on the disruption of adherens junctions in MCF-10A cells because several lines of evidence have implicated Src in regulating intercellular adhesion. 7, 8, 10, 24 To study the quantitative effects of Src activity on E-cadherin:β-catenin interactions in vivo using our protein complex ELISA, MCF-10A cells were infected with retrovirus encoding a constitutively active mutant of Src (Y527F); 25, 26 as a negative control, cells were infected with retrovirus generated using an empty vector control. Cell lysates were prepared and analyzed for the amount of E-cadherin: β-catenin complexes and for the levels of E-cadherin and β-catenin expression. All assays demonstrated a broad linear range with respect to total cell protein (For Supplemental  Fig. 2 , see http://jbx.sagepub.com/cgi/content/full/12/5/683/DC1).
Using the protein complex ELISA revealed that activated Src reduced levels of the E-cadherin:β-catenin complex by ~40% in MCF-10A cells (Fig. 6A) , corroborating reports that Src can disrupt E-cadherin-mediated adhesions in vivo. 7, 8, 10, 24 These results are consistent with our qualitative observation that subconfluent MCF-10A cells expressing activated Src formed fewer cell-cell contacts in culture as compared to their empty vector counterparts (data not shown). To determine whether the reduction in the amount of E-cadherin:β-catenin complexes correlated with a decrease in E-cadherin:β-catenin interactions or with a decreased expression of these proteins, we quantified the amount of total Ecadherin using the sandwich ELISA. MCF-10A cells expressing activated Src exhibited a reduction in E-cadherin of 40% when compared to cells infected with empty-vector control virus (Fig.  6B) . Thus, there is a striking quantitative similarity between the decrease in the levels of E-cadherin:β-catenin complexes and Ecadherin expression. In fact, when the levels of the E-cadherin: β-catenin complex are normalized to total levels of E-cadherin, the ratio is nearly equivalent in cells expressing activated Src and the negative control counterparts (Fig. 6C) .
Because Src-mediated disruption of adherens junctions in vivo correlates with tyrosine phosphorylation of both Ecadherin and β-catenin, 7, 8, 10, 24 it has been speculated that Src disrupts adherens junctions by phosphorylating β-catenin and thus reducing its binding affinity for E-cadherin. In support of this model, in vitro studies have demonstrated that Src-mediated phosphorylation of β-catenin Tyr654 causes a 6-fold decrease in the affinity of β-catenin for E-cadherin. 12 Additional in vitro studies have also shown that phosphorylation of E-cadherin by Src decreases the affinity constant of E-cadherin for β-catenin from approximately 260 nM to 4 µM in vitro. 13 Although our results are not wholly incompatible with this model, the striking correlation between Src-induced decreases in E-cadherin:β-catenin complexes and E-cadherin itself strongly suggests that active Src may reduce the levels of E-cadherin: β-catenin complexes by a simpler mechanism-namely, the downregulation of E-cadherin expression. By decreasing the availability of E-cadherin in MCF-10A cells, Src could reduce levels of the endogenous E-cadherin:β-catenin complex without modulating the protein binding affinity through phosphorylation. In another nontransformed epithelial cell line (MDCK), activation of Src induced ubiqutination and endocytosis of E-cadherin through the Hakai ubiquitin ligase, leading to decreased E-cadherin expression and the disruption of cell-cell contacts. 8 Thus, altering the expression level of E-cadherin may be a mechanism by which Src regulates adherens junctions in nontransformed epithelial cells. In fact, Src-mediated downregulation of E-cadherin may contribute to oncogenic phenomena, such as transforming growth factor β-induced epithelial-mesenchymal transition. 27 The observed 40% decrease in E-cadherin expression raises the question of the fate of its binding partner β-catenin. It is reasonable to hypothesize that a reduction in E-cadherin expression may cause a parallel decrease in β-catenin expression because when β-catenin is bound to E-cadherin, it is protected from proteasomal degradation because the degradation complex cannot bind β-catenin. 28 However, once released from E-cadherin, βcatenin is subject to degradation by the APC/axin/GSK3β/casein kinase I degradation machinery. Indeed, the β-catenin ELISA revealed that the expression level of β-catenin also decreased in cells expressing activated Src but only by a relatively modest 20% (Fig. 6B) . Compared to the 40% reduction in E-cadherin levels, the modest reduction in β-catenin levels suggests that some of the E-cadherin-free β-catenin lingers in the cell, avoiding degradation. Indeed, when the levels of E-cadherin:βcatenin complexes are normalized to total levels of β-catenin, the ratio decreases by ~25% in cells expressing activated Src (Fig. 6C) . This result suggests that among total cellular βcatenin, 25% fewer are associated with E-cadherin in response to constitutive activation of Src, which may contribute to Srcmediated activation of β-catenin-mediated transcription as reported by others. 29, 30 
CONCLUSIONS
We have developed a protein complex ELISA to quantify the level of endogenous E-cadherin:β-catenin complexes in unpurified whole-cell lysates. Furthermore, we have exploited the compatibility of our protein complex ELISA format to quantify total cellular levels of E-cadherin and β-catenin using traditional sandwich ELISAs. Using these techniques, we have characterized the quantitative differences in E-cadherin:βcatenin complexes between normal and tumorigenic cells as well as the effects of a dominant-active oncogene on E-cadherin:β-catenin complexes in vivo. These measurements provide insight into not only the expression levels of adherens junctions constituents but also their ability to form multiprotein complexes, which is an integral feature of their biological functionality. Because the association of E-cadherin and β-catenin is an established predictor of tumor cell invasiveness and patient prognosis, 1 the E-cadherin:β-catenin protein complex ELISA may prove to be a powerful tool for diagnostic characterization of tumors. In fact, other protein complex ELISAs have demonstrated that protein complexes can serve as better biomarkers of disease than individual proteins. 16, 18 In addition to the powerful prognostic value of protein:protein association data, the quantitative nature of the protein complex ELISA offers advantages over the qualitative, low-throughput techniques currently used to characterize E-cadherin:β-catenin association. As such, the E-cadherin:β-catenin ELISA is a powerful tool for quantitative characterization of cell-cell adhesion.
